Corcept Therapeutics
2.0 of 5 2 reviews Menlo Park, CA 16 to 50 Employees
Suggest Edits

Be The First To
Add Photos

Company - Public (CORT)
Biotech & Pharmaceuticals
$10 to $25 million (USD) per year

Corcept Therapeutics wants to help people who are beyond blue. The biotechnology firm is exploring treatments that regulate the presence of Cortisol, a steroid hormone associated with some psychiatric and metabolic disorders. It is developing its lead candidate Corlux, a version of the compound mifepristone (commonly known as RU-486 or the "abortion pill"), as a means to regulate release patterns of cortisol in patients with psychotic depression, as well as those experiencing weight gain from taking other antipsychotic medications. The company is also investigating whether... More

Working at Corcept Therapeutics

Posted by employees

Employees are “Dissatisfied”   2 ratings


100% Approve of the CEO   2 ratings

Corcept Therapeutics CEO and Director Joseph K. Belanoff

Joseph K. Belanoff

CEO and Director

It could be so much better if company cared about its employees

 Current Employee in Menlo Park, CA

Pros: The salaries are very competitive, even high compared to other pharmaceutical companies. CEO is warm, communicative and the employees like and respect him. Full Review

More Corcept Therapeutics Ratings & Reviews ( 2)

Corcept Therapeutics Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Worked for Corcept Therapeutics? Contribute to the Community!

Financial Information

Glassdoor is your free inside look at what it's like to work at Corcept Therapeutics - including salaries, reviews, office photos, and more. All content posted anonymously by employees working at Corcept Therapeutics.